US equities |
NVDA $186.64 ▲+2.78% MU $690.00 ▲+5.12% AMD $449.04 ▲+11.04% SPCX $134.27 ▲+8.62% AAPL $342.37 ▼-0.52% SNDK $835.06 ▲+3.55% MSFT $530.61 ▼-0.99% TSLA $358.22 ▲+4.23%
FinancialContent

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

4.790 +0.030 (+0.63%)
Delayed Quote Updated: 3:59 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript ↗
Data licensing revenue surged past full-year fiscal 2026 totals in single quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology Q1 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology... 
Via MarketBeat
Topics Earnings
Champions Oncology (NASDAQ:CSBR) Shares Jump as Q1 Margins Expand and Adjusted EBITDA Turns Higher ↗
Via Chartmill
News headline image
Champions Oncology Reports Revenue of $15.2 Million
Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000 
From Champions Oncology, Inc.
Via ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
Via Chartmill
Topics Earnings
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
Via Chartmill
News headline image
Insights Ahead: Champions Oncology's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Q4 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported record revenue for fiscal 2026 and positive adjusted EBITDA in every quarter of the year, supported by growth in its core Translational Oncology Solutions, or... 
Via MarketBeat
Topics Earnings
News headline image
Champions Oncology Reports Record Annual Revenue of $59 Million
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Via ACCESS Newswire
News headline image
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Via ACCESS Newswire
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Champions Oncology (CSBR) Earnings Transcript 
Via The Motley Fool
News headline image
Champions Oncology Reports Revenue of $16.6 Million
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Via ACCESS Newswire
News headline image
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
This SaaS provider enables brands to personalize customer engagement across digital channels using data-driven orchestration tools. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
This marketing technology provider delivers data-driven automation and consumer insights to enterprise clients across multiple channels. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
Kodiak AI, Inc. delivers AI-powered navigation software for trucking, defense, and industrial fleets using proprietary sensor technology. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
Sprinklr delivers a unified platform for enterprise customer experience management, serving global brands with integrated digital solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Champions Oncology (CSBR) Earnings Call Transcript ↗
Champions Oncology (CSBR) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Champions Oncology (CSBR) Earnings Transcript 
Via The Motley Fool
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins. 
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
Via ACCESS Newswire
News headline image
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
Via ACCESS Newswire
News headline image
Earnings Scheduled For September 15, 2025 ↗
 
Via Benzinga
News headline image
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 Next >